Crossmark

Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial

Crossref DOI link: https://doi.org/10.1186/s12906-019-2483-y

Published Online: 2019-03-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jung, Su-Jin

Jung, Eun-Soo

Choi, Eun-Kyung

Sin, Hong-Sig

Ha, Ki-Chan

Chae, Soo-Wan http://orcid.org/0000-0003-3660-8272
License Information

Text and Data Mining valid from 2019-03-29
More Information

Article History

Received: 9 May 2018

Accepted: 13 March 2019

First Online: 29 March 2019

Ethics approval and consent to participate

: The study was conducted according to the Declaration of Helsinki. The research protocol was approved by the Institutional Review Board (IRB) of Chonbuk National University Hospital. All participants gave written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.